| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |